World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
25306
World Ranking
1439
National Ranking
121

Medicine

D-Index
83
Citations
25378
World Ranking
15604
National Ranking
1436

Overview

Helen Chapel is affiliated with the University of Oxford in the United Kingdom and has contributed to research across several related fields within medicine and immunology. Their published work mainly targets immunodeficiency and autoimmune disorders as well as topics intersecting pulmonary medicine and genetics.

The scientist's recent publications include:

  • The PID Principles of Care: Where Are We Now? A Global Status Report Based on the PID Life Index (2021), Frontiers in Immunology
  • Histology of Interstitial Lung Disease in Common Variable Immune Deficiency (2020), Frontiers in Immunology
  • Protocol for the unclassified primary antibody deficiency (unPAD) study: Characterization and classification of patients using the ESID online Registry (2022), PLoS ONE
  • On the relevance of immunodeficiency evaluation in haematological cancer (2021), Hematological Oncology

Their frequent co-authors have included Silvia Sánchez-Ramón, Julia Nordin, Leire Solís, J Prévot, and Nizar Mahlaoui.

Publication venues where their research appears frequently include Frontiers in Immunology, PLoS ONE, and Hematological Oncology.

Helen Chapel's main fields of study cover Medicine and Immunology and Microbiology, supported by publications in these areas. Their work further breaks down into subfields such as Immunology, Pulmonary and Respiratory Medicine, Genetics, Epidemiology, and Infectious Diseases.

The primary topics reflected in their publications emphasize:

  • Immunodeficiency and Autoimmune Disorders
  • Immune responses and vaccinations
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cystic Fibrosis Research Advances
  • Blood disorders and treatments
  • Parvovirus B19 Infection Studies

Best Publications

  • Pyogenic Bacterial Infections in Humans with MyD88 Deficiency

    Horst Von Bernuth;Capucine Picard;Capucine Picard;Zhongbo Jin;Rungnapa Pankla;Rungnapa Pankla

  • The EUROclass trial: defining subgroups in common variable immunodeficiency

    Claudia Wehr;Teemu Kivioja;Christian Schmitt;Berne Ferry

  • Common variable immunodeficiency disorders: division into distinct clinical phenotypes

    Helen Chapel;Mary Lucas;Martin Lee;Janne Bjorkander

  • International consensus document (icon): common variable immunodeficiency disorders

    Francisco A. Bonilla;Isil Barlan;Helen Chapel;Beatriz Tavares Costa-Carvalho

  • Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

    U Salzer;H M Chapel;A D B Webster;Q Pan-Hammarström

  • Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency

    Waleed Al-Herz;Aziz Bousfiha;Jean-Laurent Casanova;Jean-Laurent Casanova;Helen Chapel

  • Primary immunodeficiencies: 2009 update

    Luigi D. Notarangelo;Alain Fischer;Raif S. Geha;Jean-Laurent Casanova

  • Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

    Raif S. Geha;Luigi D. Notarangelo;Jean Laurent Casanova;Helen Chapel

  • The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity

    Markus G. Seidel;Gerhard Kindle;Benjamin Gathmann;Isabella Quinti

  • Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

    D.R.W. Jayne;H. Chapel;D. Adu;S. Misbah

  • Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

    Mary Lucas;Martin Lee;Jenny Lortan;Eduardo Lopez-Granados

  • Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells

    Ludovic de Beaucoudrey;Ludovic de Beaucoudrey;Anne Puel;Anne Puel;Orchidée Filipe-Santos;Orchidée Filipe-Santos;Aurélie Cobat;Aurélie Cobat

  • Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

    Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh

  • Update in understanding Common Variable Immunodeficiency Disorders (CVIDs) and the management of patients with these conditions

    Helen Chapel;Charlotte Cunningham-Rundles

  • Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity

    Cheng Lung Ku;Horst Von Bernuth;Horst Von Bernuth;Capucine Picard;Shen Ying Zhang

  • Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial.

    Robert Peter Gale;Helen M Chapel;Christopher Bunch

  • Lymphocyte subset reference ranges in adult Caucasians.

    T. Reichert;M. DeBruyère;V. Deneys;T. Tötterman

  • Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Jenny C. Taylor;Jenny C. Taylor;Hilary C. Martin;Stefano Lise;John Broxholme

  • The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.

    H. M. Chapel;G. P. Spickett;D. Ericson;W. Engl

  • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)

    Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot

Frequent Co-Authors

Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Charlotte Cunningham-Rundles
Charlotte Cunningham-Rundles Icahn School of Medicine at Mount Sinai
Capucine Picard
Capucine Picard Université Paris Cité
Alain Fischer
Alain Fischer Collège de France
Lennart Hammarström
Lennart Hammarström Karolinska Institute
Horst von Bernuth
Horst von Bernuth Charité - University Medicine Berlin
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Hans D. Ochs
Hans D. Ochs University of Washington
Hakon Hakonarson
Hakon Hakonarson Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open additional career opportunities. Accelerated nursing programs, such as the easiest absn to get into, offer a fast track to becoming a registered nurse. These programs are ideal for individuals transitioning from other fields who want to enter the healthcare workforce quickly.

If you prefer a focus on practical nursing skills, considering which lpn programs are easiest to get into can help you find accessible options. Licensed Practical Nurse (LPN) programs serve as a stepping stone for many towards more advanced nursing roles and provide valuable patient care experience relevant in immunology-related fields.

For advanced practice nurses, the easiest nurse practitioner degree programs provide opportunities to specialize and deepen clinical expertise. These programs prepare graduates for highly skilled roles that often intersect with immunologic care and research.

Specifically in mental health nursing, the top pmhnp programs combine psychiatric knowledge with practical clinical placements, helping nurses understand the immune system's role in mental health. Such integrative education is increasingly valuable in multidisciplinary healthcare teams.

Best Scientists Citing Helen Chapel

Trending Scientists

Recently Published Articles